TrialStem cell research & therapy2023

Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease.

Pawan Kumar Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.